Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.

Calverley, Peter M ; Postma, Dirkje S ; Anzueto, Antonio R ; Make, Barry J ; Eriksson, Göran LU ; Peterson, Stefan and Jenkins, Christine R (2016) In The International Journal of Chronic Obstructive Pulmonary Disease 11. p.381-390
Abstract
Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
The International Journal of Chronic Obstructive Pulmonary Disease
volume
11
pages
381 - 390
publisher
Dove Medical Press Ltd.
external identifiers
  • pmid:26952309
  • scopus:84959365536
  • pmid:26952309
  • wos:000370975600001
ISSN
1178-2005
DOI
10.2147/COPD.S93303
language
English
LU publication?
yes
id
a59be422-5676-41ae-adf6-82b459adc212 (old id 8853070)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26952309?dopt=Abstract
date added to LUP
2016-04-01 11:14:11
date last changed
2022-03-05 02:34:34
@article{a59be422-5676-41ae-adf6-82b459adc212,
  abstract     = {{Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.}},
  author       = {{Calverley, Peter M and Postma, Dirkje S and Anzueto, Antonio R and Make, Barry J and Eriksson, Göran and Peterson, Stefan and Jenkins, Christine R}},
  issn         = {{1178-2005}},
  language     = {{eng}},
  pages        = {{381--390}},
  publisher    = {{Dove Medical Press Ltd.}},
  series       = {{The International Journal of Chronic Obstructive Pulmonary Disease}},
  title        = {{Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.}},
  url          = {{http://dx.doi.org/10.2147/COPD.S93303}},
  doi          = {{10.2147/COPD.S93303}},
  volume       = {{11}},
  year         = {{2016}},
}